Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
National Institute of Cardiology, Laranjeiras, Brazil
Methods and Analyses: This is a double-blind, placebo-controlled clinical trial in which patients with hypertension will be randomly assigned to two groups to receive either nitrate powder supplementation or placebo for a duration of 60 days. The primary outcome will be the reduction in blood pressure levels. Secondary outcomes will include systemic microvascular reactivity and quality of life.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Resistant hypertensive patients, with a diagnosis documented in medical records, without any change in medication or increase in dosage in the past 30 days.
You may not be if
Patients will be excluded from the study if they have: neoplasms, heart failure, are using medications containing nitrate in their formulation, or have undergone renal denervation.
